Lipid-lowering medication is associated with decreased risk of diabetic retinopathy and the need for treatment in patients with type 2 diabetes: A real-world observational analysis of a health claims database

Treatment patterns in hyperlipidaemia patients based on administrative claim databases in Japan

(2018) Mayumi Wake et al.   ATHEROSCLEROSIS

Global Estimates on the Number of People Blind or Visually Impaired by Diabetic Retinopathy: A Meta-analysis From 1990 to 2010

(2016) Janet L. Leasher et al.   DIABETES CARE

Association Between Severe Hypoglycemia and Cardiovascular Disease Risk in Japanese Patients With Type 2 Diabetes

(2016) Atsushi Goto et al.   Journal of the American Heart Association

Effect of atorvastatin on diabetic rat endothelial cells and retinal lesions

(2015) M.C. Bi et al.   GENETICS AND MOLECULAR RESEARCH

Association between Statin Use and Cancer: Data Mining of a Spontaneous Reporting Database and a Claims Database

(2015) Mai Fujimoto et al.   International Journal of Medical Sciences

High-Risk Atherosclerotic Cardiovascular Disease in a Real-World Employed Japanese Population: Prevalence, Cardiovascular Event Rates, and Costs

(2015) Keith L Davis et al.   Journal of Atherosclerosis and Thrombosis

Low intravitreal angiopoietin-2 and VEGF levels in vitrectomized diabetic patients with simvastatin treatment

(2014) Raimo Tuuminen et al.   ACTA OPHTHALMOLOGICA

Atorvastatin-mediated protection of the retina in a model of diabetes with hyperlipidemia

(2014) Rosa Fernandes et al.   CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY

An Update on the Molecular Actions of Fenofibrate and Its Clinical Effects on Diabetic Retinopathy and Other Microvascular End Points in Patients With Diabetes

(2014) J. E. Noonan et al.   DIABETES

New treatments for diabetic retinopathy

(2014) A. Das et al.   DIABETES OBESITY & METABOLISM

The Effects of Medical Management on the Progression of Diabetic Retinopathy in Persons with Type 2 Diabetes

(2014) Emily Y. Chew et al.   OPHTHALMOLOGY

Statin Medication Use and the Development of Proliferative Diabetic Retinopathy Among Patients with Type 2 Diabetes, Hypertension, and Hyperlipidemia

(2014) Y Han et al.   VALUE IN HEALTH

Statin use before diabetes diagnosis and risk of microvascular disease: a nationwide nested matched study

(2014) Sune F Nielsen et al.   Lancet Diabetes & Endocrinology

Identification of Persons With Incident Ocular Diseases Using Health Care Claims Databases

(2013) Joshua D. Stein et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

Association Between Plasma Triglycerides and High-Density Lipoprotein Cholesterol and Microvascular Kidney Disease and Retinopathy in Type 2 Diabetes Mellitus

(2013) Frank M. Sacks et al.   CIRCULATION

Serum Apolipoproteins Are Associated With Systemic and Retinal Microvascular Function in People With Diabetes

(2012) M. B. Sasongko et al.   DIABETES

Simvastatin increases circulating endothelial progenitor cells and reduces the formation and progression of diabetic retinopathy in rats

(2012) Wei Zhang et al.   EXPERIMENTAL EYE RESEARCH

Do Persons with Diabetes Benefit from Combination Statin and Fibrate Therapy?

(2012) Paul D. Rosenblit   Current Cardiology Reports

Doubly Robust Estimation of Causal Effects

(2011) Michele Jonsson Funk et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Retinal Arteriolar Narrowing and Subsequent Development of CKD Stage 3: The Multi-Ethnic Study of Atherosclerosis (MESA)

(2011) Joanne Wen Yee Yau et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Incidence and progression of diabetic retinopathy in Japanese adults with type 2 diabetes: 8 year follow-up study of the Japan Diabetes Complications Study (JDCS)

(2011) R Kawasaki et al.   DIABETOLOGIA

Effects of Medical Therapies on Retinopathy Progression in Type 2 Diabetes

(2010)   NEW ENGLAND JOURNAL OF MEDICINE

Effect of a Multifactorial Intervention on Mortality in Type 2 Diabetes

(2008) Peter Gæde et al.   NEW ENGLAND JOURNAL OF MEDICINE